ArticleESMO open2026

Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancer.

Y Katayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.